With regard to obesity and fatty liver, we postulate that insulin clearance increases first to compensate for the high concentration of circulating insulin; then, it declines when insulin levels become too high, and obesity comorbidities and altered glucose homeostasis manifest. The gene discussed is INS; the disease is Obesity.